Centre for Evidence in Transplantation, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
Great Ormond Street Hospital for Children, London, United Kingdom.
Transpl Int. 2022 Mar 17;35:10315. doi: 10.3389/ti.2022.10315. eCollection 2022.
Preemptive kidney transplantation (PKT) is performed prior to dialysis initiation to avoid dialysis-related morbidity and mortality in children and adolescents. We undertook a systematic review to compare clinical outcomes in PKT versus kidney transplantation after dialysis initiation in paediatric patients. The bibliographic search identified studies that compared paediatric recipients of a first or subsequent, living or deceased donor PKT versus non-preemptive kidney transplant. Methodological quality was assessed for all studies. Data were pooled using the random-effects model. Twenty-two studies ( = 22,622) were included. PKT reduced the risk of overall graft loss (relative risk (RR) .57, 95% CI: .49-.66) and acute rejection (RR: .81, 95% CI: .75-.88) compared to transplantation after dialysis. Although no significant difference was observed in overall patient mortality, the risk of patient death was found to be significantly lower in PKT patients with living donor transplants (RR: .53, 95% CI: .34-.83). No significant difference was observed in the incidence of delayed graft function. Evidence from observational studies suggests that PKT is associated with a reduction in the risk of acute rejection and graft loss. Efforts should be made to promote and improve rates of PKT in this group of patients (PROSPERO). https://clinicaltrials.gov/, CRD42014010565.
抢先肾移植(PKT)是在开始透析之前进行的,以避免儿童和青少年因透析相关的发病率和死亡率。我们进行了一项系统评价,比较了 PKT 与透析后开始的儿童患者肾移植的临床结果。文献检索确定了比较首次或后续活体或已故供体 PKT 与非抢先肾移植的儿科受者的研究。对所有研究进行了方法学质量评估。使用随机效应模型对数据进行了汇总。纳入了 22 项研究(= 22622)。与透析后移植相比,PKT 降低了总体移植物丢失(相对风险(RR).57,95%CI:.49-.66)和急性排斥反应(RR:.81,95%CI:.75-.88)的风险。尽管在总体患者死亡率方面没有观察到显著差异,但在接受活体供体移植的 PKT 患者中,患者死亡的风险显著降低(RR:.53,95%CI:.34-.83)。延迟移植物功能的发生率没有观察到显著差异。来自观察性研究的证据表明,PKT 与降低急性排斥反应和移植物丢失的风险有关。应努力提高这组患者的 PKT 率(PROSPERO)。https://clinicaltrials.gov/,CRD42014010565。